Lifeboat Foundation

https://www.youtube.com/watch?app=desktop&v=qn8ahPBFVSs

Here Dr Tan introduces geranylgeraniol (GG), talks about its discovery and its importance in human metabolism.

Wellness Extract 5% discount Code MODERN10
GG Essential https://collabs.shop/ivoshz.
Vitamin E, Delta Gold https://collabs.shop/gfjyof.
Bio Quinol with GG https://collabs.shop/wm9cce.
Renue By Science 10% : Code MHS https://tinyurl.com/35jyuk33
CoQ10 https://bit.ly/4bX3I6P\r.
ProHealth 15% discount Code MODERN: https://prohealth.pxf.io/Vm9BoA
CoQ10 https://prohealth.pxf.io/LX12N0
DoNotAge 10% discount code MHS https://tinyurl.com/6dbvhv87
Pure NMN https://tinyurl.com/wyzj2f3d.
Nuchido Time+ 20% discount of first purchase with code MODERN20 https://nuchido.com/MODERN
NOVOS https://novos.sjv.io/QyWP7o code 5OFFMHS
NMN Bio 10% off all products https://tinyurl.com/2af2v2fw Code ModernHealthSpan10 in link.
☕If you would like to support our channel, we’d love a coffee…thank you! https://www.buymeacoffee.com/mhealthspan.

Continue reading “A Promising Novel Anti-Aging Compound GG — Geranylgeraniol Explained By It Discoverer Dr Barrie Tan” »

K-Ras mutations are all too familiar as drivers of cancer. And until recently, they were considered all but undruggable. But ever since the arrival of sotorasib and adagrasib—two FDA-approved K-Ras-G12C inhibitors—K-Ras mutations have had the distinction of being somewhat druggable. Even better, K-Ras mutations may soon become yet more druggable. Scientists at the University of California, San Francisco, have found a way to target K-Ras-G12D mutations, which are especially prevalent in pancreatic ductal adenocarcinoma.

The scientists were led by Kevan Shokat, PhD, a professor in the department of cellular and molecular pharmacology. Back in 2013, Shokat and colleagues developed the first K-Ras-G12C inhibitors. And today, in Nature Chemical Biology, they present a paper (“Strain-release alkylation of Asp12 enables mutant selective targeting of K-Ras-G12D”) describing how they designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable and perhaps even curable condition.

“[Covalent] inhibition of G12D, the most frequent K-Ras mutation particularly prevalent in pancreatic ductal adenocarcinoma, has remained elusive due to the lack of aspartate-targeting chemistry,” the article’s authors wrote. “Here we present a set of malolactone-based electrophiles that exploit ring strain to crosslink K-Ras-G12D at the mutant aspartate to form stable covalent complexes.”

Every time a cell divides, its DNA is duplicated so that the two daughter cells have the same genetic material as their parent. This means that, millions of times a day, a biochemical wonder takes place in the body: the copying of the DNA molecule. It is a high-precision job carried out by specific proteins and includes systems to protect against potential errors that could lead to diseases such as cancer.

One of these anti-failure systems has just been discovered by researchers in the DNA Replication Group at the Spanish National Cancer Research Centre (CNIO), led by Juan Méndez. It is based on a protein that ensures that DNA is copied only once, as it should be, and not twice or more.

The work is published in The EMBO Journal.

Scientists from the University of Rochester have developed new electrochemical approaches to clean up pollution from “forever chemicals” found in clothing, food packaging, firefighting foams, and a wide array of other products. A new Journal of Catalysis study describes nanocatalysts developed to remediate per-and polyfluoroalkyl substances known as PFAS.

The researchers, led by assistant professor of chemical engineering Astrid Müller, focused on a specific type of PFAS called Perfluorooctane sulfonate (PFOS), which was once widely used for stain-resistant products but is now banned in much of the world for its harm to human and animal health. PFOS is still widespread and persistent in the environment despite being phased out by US manufacturers in the early 2000s, continuing to show up in water supplies.

In an article published in the Journal of Materials Chemistry C, Brazilian researchers describe a strategy to enhance the efficiency and stability of solar cells made of perovskite, a semiconductor material produced in the laboratory. The results of the project could be highly positive for the future of the solar power sector.

Developed by researchers at São Paulo State University (UNESP) in Bauru, Brazil, the method involves the use of a class of materials known as MXenes, a family of two-dimensional materials with a graphene-like structure combining transition metals, carbon and/or nitrogen, and surface functional groups such as fluoride, oxygen or hydroxyl. Their properties include high electrical conductivity, good thermal stability, and high transmittance (relating to the amount of light that passes through a substance without being reflected or absorbed).

In the study, the MXene Ti3C2Tx was added to polymethyl methacrylate (PMMA) to form a passivation coating, which was spin-coated on top of the perovskite layer of inverted solar cells. Passivation coatings are designed to mitigate possible defects in polycrystalline solids (perovskite in this case) due to interaction with the environment or to their internal structure.

Robots and cameras of the future could be made of liquid crystals, thanks to a new discovery that significantly expands the potential of the chemicals already common in computer displays and digital watches.

The findings, a simple and inexpensive way to manipulate the molecular properties of liquid crystals with light exposure, are now published in Advanced Materials.

“Using our method, any lab with a microscope and a set of lenses can arrange the liquid crystal alignment in any pattern they’d want,” said author Alvin Modin, a doctoral researcher studying physics at Johns Hopkins. “Industrial labs and manufacturers could probably adopt the method in a day.”

Quantum computers promise to efficiently predict the structure and behaviour of molecules. This Perspective explores how this could overcome existing challenges in computational drug discovery.

Scientists at the National University of Singapore (NUS) have created a microporous covalent organic framework with dense donor–acceptor lattices and engineered linkages for the efficient and clean production of hydrogen peroxide (H₂O₂) through the photosynthesis process with water and air.

Traditional industrial production of H₂O₂ via the anthraquinone process using hydrogen and oxygen, is highly energy-intensive. This approach employs toxic solvents and expensive noble-metal catalysts, and generates substantial waste from side reactions.

Paclitaxel is the world’s best-selling plant-based anticancer drug and one of the most effective anticancer drugs over the past 30 years. It is widely used in the treatment of various types of cancer, including breast cancer, lung cancer, and ovarian cancer.

In the late 1990s and early 21st century, the annual sales of paclitaxel exceeded $1.5 billion and reached $2.0 billion in 2001, making it the best-selling drug in 2001. In 2019, the market for paclitaxel and its derivatives was approximately $15 billion, and it is expected to reach $20 billion by 2025.

As an anticancer drug, the molecular structure of paclitaxel is extremely complex, with highly oxidized, intricate bridged rings and 11 stereocenters, making it widely recognized as one of the most challenging natural products to synthesize chemically. Since the first total synthesis of paclitaxel was reported by the Holton and Nicolaou research groups in 1994, more than 40 research teams have been engaged in the total synthesis of paclitaxel.